Covid: Trials check the efficacy of Oxford-AstraZeneca vaccine on youngsters

A medical trial testing the security and effectiveness of the Oxford-AstraZeneca coronavirus vaccine on youngsters has begun. Round 300 volunteers aged six to 17 are collaborating within the examine, which can see 240 youngsters obtain the Covid-19 vaccine, with the rest given a management meningitis vaccine. Members might be given a second dose of the vaccine between 4 and 12 weeks later.

Supply hyperlink